RESUMEN
AIMS: To compare the results of breast cancer sections with HercepTesttrade mark immunohistochemistry (IHC) scores ranging from 0 to 3+ with fluorescence in situ hybridisation (FISH) for HER2 amplification. The HER2 digital scoring application of the Micrometastasis Detection System (MDS) was used, together with manual scoring of FISH and HercepTest, to determine whether this system provides an accurate alternative. METHODS: Paraffin wax embedded sections were stained using HercepTest and analysed by eye and automated quantitative image analysis. FISH was performed using the PathVysion fluorescent probe and scored by eye and automated quantitative image analysis using MDS. RESULTS: Of 114 cases, 26% were amplified by FISH, whereas only 18% scored 3+; 32% of IHC 2+ cases were amplified by FISH, and one showed borderline amplification. Six percent of IHC negative cases (0 or 1+) were amplified by FISH, and one showed borderline amplification. Of IHC 3+ cases, 10% were non-amplified by FISH. Classification discrepancies were seen in 18% of HercepTest cases scored by eye and using the MDS system. MDS was consistent with visual FISH scoring and correctly differentiated most ambiguous visual IHC scores. CONCLUSIONS: FISH provides a more accurate and consistent scoring system for determining HER2 amplification than HercepTest. The MDS system provides a reliable, consistent alternative to visual IHC and FISH scoring. IHC is still a valuable technique to aid in identification of isolated or heterogeneous tumour populations for subsequent FISH analysis, and a combined FISH and HercepTest approach to all breast cancer cases may be the most efficient strategy.
Asunto(s)
Biomarcadores de Tumor/metabolismo , Neoplasias de la Mama/metabolismo , Receptor ErbB-2/metabolismo , Femenino , Humanos , Procesamiento de Imagen Asistido por Computador/métodos , Inmunohistoquímica , Hibridación Fluorescente in Situ/métodos , Proteínas de Neoplasias/metabolismo , Adhesión en Parafina , Reproducibilidad de los ResultadosRESUMEN
OBJECTIVE: Early research into Wolf-Hirschhorn syndrome (WHS) described a high mortality and no relationship between deletion size and phenotype. This may need to be revised in the light of improved cytogenetic resolution and medical care. We have collected epidemiological data to allow the calculation of birth incidence and mortality figures. In addition, we have investigated the possibility of a relationship between deletion size and mortality. METHOD: Information relating to past and present cases diagnosed in the UK was collected by multiple ascertainment. RESULTS: A total of 159 cases were collected. The status (alive or dead) was determined for 146, of whom 96 are alive, 37 had died, and 13 were detected on prenatal diagnostic tests. A minimum birth incidence of 1 in 95 896 was calculated. The crude infant mortality rate was 17% (23/132) and in the first two years of life the mortality rate was 21% (28/132). Cases with large de novo deletions (proximal to and including p15.2) were more likely to have died than those with smaller deletions (odds ratio=5.7, 95% CI=1.7-19.9) after adjusting for age. A comparison of survival curves for de novo deletions and translocations did not show a statistically significant difference (p=0.11). The median survival time for de novo deletions was 34+ years while for translocation cases it was 18+ years. CONCLUSIONS: The mortality rate is lower than previously reported. There is a statistically significant relationship between deletion size and overall risk of death in de novo deletion cases. The difference in survival curves between de novo deletions and translocations is not statistically significant.
Asunto(s)
Anomalías Múltiples/genética , Anomalías Múltiples/mortalidad , Deleción Cromosómica , Esperanza de Vida , Anomalías Múltiples/epidemiología , Adulto , Causas de Muerte , Niño , Preescolar , Rotura Cromosómica/genética , Estudios de Cohortes , Femenino , Humanos , Incidencia , Lactante , Recién Nacido , Cariotipificación , Masculino , Oportunidad Relativa , Fenotipo , Infecciones del Sistema Respiratorio/complicaciones , Infecciones del Sistema Respiratorio/genética , Infecciones del Sistema Respiratorio/mortalidad , Convulsiones/complicaciones , Convulsiones/genética , Convulsiones/mortalidad , Análisis de Supervivencia , Síndrome , Translocación Genética/genética , Reino UnidoRESUMEN
Prediction of recurrence after resection of benign meningiomas represents a significant clinical problem. A prospective study commenced in 1984 aimed to elucidate the molecular mechanisms involved in the development of abnormal karyotype and tumour recurrence in meningiomas. Expression of key cell cycle regulators p53, p21, mdm2 and proliferating cell nuclear antigen (PCNA) were studied by immunohistochemistry in 85 tumours for which follow-up data was available. It was found that most tumours expressed p53, p21 and PCNA, with significant correlations between expression of p53 and both p21 and PCNA. As PCNA fulfils a multifunctional role its expression may be an unreliable indicator of proliferation in benign tumours. The degree of tumour excision remains the best prognostic indicator while p53 is the main predictor of abnormal karyotype. Karyotype is not however, related to prognosis. Incompletely excised tumours which expressed high levels of p53 and p21 did not recur. It is suggested that this is indicative of a fully functional p53-mediated DNA damage response mechanism. Rather than contributing to tumour progression, p53 is fulfilling its role as guardian of the genome in benign meningiomas. This study shows that induction of senescence may be an important tumour suppressor mechanism in benign tumours.
Asunto(s)
Senescencia Celular/fisiología , Neoplasias Meníngeas/metabolismo , Meningioma/metabolismo , Recurrencia Local de Neoplasia/prevención & control , Proteínas Nucleares , Proteína p53 Supresora de Tumor/biosíntesis , Adulto , Anciano , Anciano de 80 o más Años , Núcleo Celular/metabolismo , Núcleo Celular/patología , Inhibidor p21 de las Quinasas Dependientes de la Ciclina , Ciclinas/biosíntesis , Supervivencia sin Enfermedad , Femenino , Humanos , Inmunohistoquímica , Cariotipificación , Antígeno Ki-67/biosíntesis , Masculino , Neoplasias Meníngeas/diagnóstico , Neoplasias Meníngeas/patología , Meningioma/diagnóstico , Meningioma/patología , Persona de Mediana Edad , Proteínas de Neoplasias/biosíntesis , Valor Predictivo de las Pruebas , Antígeno Nuclear de Célula en Proliferación/biosíntesis , Estudios Prospectivos , Proteínas Proto-Oncogénicas/biosíntesis , Proteínas Proto-Oncogénicas c-mdm2 , Resultado del TratamientoAsunto(s)
Cromosomas Humanos Par 4 , Duplicación de Gen , Adulto , Preescolar , Aberraciones Cromosómicas , Pintura Cromosómica , Síndrome de Down/genética , Femenino , Humanos , Masculino , FenotipoRESUMEN
Two brothers with Duchenne muscular dystrophy have an inversion of the X chromosome, 46, Y, inv(X) (p11.2p21.2). Because their mother is an unaffected carrier of the inversion, this confirms that maternal passage of a structurally abnormal X chromosome can cause dystrophinopathy in males. Our experience suggests that as well as molecular genetic analysis, karyotyping can be useful in Xp21 muscular dystrophy.
Asunto(s)
Inversión Cromosómica , Distrofias Musculares/genética , Cromosoma X/genética , Adulto , Humanos , MasculinoRESUMEN
We report on the clinical and cytogenetic assessment of five cases of Down syndrome phenotype with either a partial duplication of chromosome 21 or a normal karyotype, and we quote a case of del (21q) syndrome. Down syndromes with a partial duplication of chromosome 21 (as well as cases of del (21q), which are partly the phenotypic countertype of trisomy 21) are of paramount importance in the understanding of genes involved in the phenotype of Down syndrome. The goal is to find the relevant genes implicated in the main traits of Down syndrome (i.e. mental retardation, Alzheimer disease, and serious visceral malformations). Such a goal, in our opinion, cannot be reached just by publishing the genotype and the phenotype of a small cohort of patients: 1. a sufficient number of accurate cases is needed, and 2. data have to be computerized for definite conclusions to be reached. The main aims of this report are to present our study protocol and to invite colleagues to participate in a collaborative study in order to collect a maximum of these (rare) cases.
Asunto(s)
Cromosomas Humanos Par 21 , Síndrome de Down/genética , Eliminación de Gen , Familia de Multigenes , Adolescente , Adulto , Niño , Preescolar , Protocolos Clínicos , Síndrome de Down/patología , Síndrome de Down/fisiopatología , Femenino , Estudios de Seguimiento , Humanos , Cooperación Internacional , Cariotipificación , Masculino , Persona de Mediana Edad , FenotipoRESUMEN
During a study of lissencephaly in England and Wales, 23 children were identified with this diagnosis. They were classified as follows: three children had Miller-Dieker syndrome (MDS), 13 had isolated lissencephaly sequence (ILS), two had type II lissencephaly, and five children were reclassified as focal or diffuse cortical dysplasia. Microdeletions of chromosome 17p13.3, also known as the Miller-Dieker critical region, have been associated with both MDS and ILS. We used the commercially available Oncor probe for fluorescent in situ hybridisation (FISH) studies on 14 patients and a further four were studied elsewhere. Deletions were identified in all three MDS patients and two of the ILS patients. These results are consistent with previously reported data. No deletions were found in those patients with focal or diffuse cortical dysplasia. In addition, a CA repeat polymorphism which maps to the Miller-Dieker critical region was studied in 12 families and was informative in nine; the results were consistent with the FISH data. We conclude that FISH is a reliable method to detect deletions in patients with MDS and ILS and also useful to identify chromosome rearrangements in their parents which are not detected by conventional cytogenetic analysis. The PCR assay, if informative, is also reliable and a useful alternative if only DNA is available. None of the five children with atypical radiological features had a deletion. We therefore suggest that as well as looking for other aetiologies a careful review of the diagnosis should be made of the MDS or ILS cases in whom a deletion is not found.
Asunto(s)
Corteza Cerebral/anomalías , Corteza Cerebral/fisiología , Cromosomas Humanos Par 17/genética , Hibridación Fluorescente in Situ , Reacción en Cadena de la Polimerasa/métodos , Eliminación de Secuencia , Encéfalo/anomalías , Encéfalo/fisiología , Movimiento Celular , Inglaterra , Eliminación de Gen , Humanos , Neuronas/citología , Polimorfismo de Longitud del Fragmento de Restricción , Secuencias Repetitivas de Ácidos NucleicosRESUMEN
An interstitial deletion of the region q22.1-->q22.3 of chromosome 14 is described in a child with bilateral anophthalmia, dysmorphic features including micrognathia, small tongue, and high arched palate, developmental and growth retardation, undescended testes with a micropenis, and hypothyroidism. Interstitial deletions of the long arm of chromosome 14 are extremely rare, but this case seems to confirm that the region q22 is specifically concerned with pituitary and eye development.
Asunto(s)
Anomalías Múltiples/genética , Anoftalmos/genética , Deleción Cromosómica , Cromosomas Humanos Par 14 , Hipófisis/anomalías , Cráneo/anomalías , Preescolar , Bandeo Cromosómico , Discapacidades del Desarrollo/genética , Huesos Faciales/anomalías , Citometría de Flujo , Genitales Masculinos/anomalías , Humanos , Hipotiroidismo/genética , Cariotipificación , MasculinoRESUMEN
A phenotypically female fetus with campomelic dysplasia and a de novo reciprocal translocation, 46,XY,t(2;17) (q35;q23-24), is presented. This is the second case of campomelic dysplasia in which a rearrangement involving the long arm of chromosome 17 has been identified, indicating that this is likely to be the site of the campomelic dysplasia locus.
Asunto(s)
Cromosomas Humanos Par 17 , Cromosomas Humanos Par 2 , Osteocondrodisplasias/genética , Translocación Genética , Anomalías Múltiples/genética , Anomalías Múltiples/patología , Bandeo Cromosómico , Trastornos del Desarrollo Sexual , Feto/patología , Humanos , Masculino , Osteocondrodisplasias/patologíaRESUMEN
In a series of 50 meningiomas, cytogenetic studies showed that almost half had a normal diploid karyotype. The remainder had monosomy 22, some with a normal diploid line also present. The initial monosomy was often followed by further chromosome loss, and occasionally by structural abnormalities, some with distinctive characteristics. Chromosomes most often involved in structural rearrangements were 1, 14, 10, and 19, and those most often lost were 17 and Y. The type of chromosome abnormalities seen were similar to those described for senescent human cell cultures, which suggests that common chromosomal mechanisms may be operative in benign tumors and senescent cells. Although meningiomas occur more commonly in females, the chromosomally abnormal tumors are distributed evenly between males and females. Within the group of tumors with structural chromosomal abnormality, there seems to be a bias toward meningotheliomatous histology, but otherwise the karyotype changes seen independent of the histologic type of tumor.
Asunto(s)
Aberraciones Cromosómicas , Neoplasias Meníngeas/genética , Meningioma/genética , Marcadores Genéticos , Humanos , Cariotipificación , Neoplasias Meníngeas/patología , Meningioma/patología , Ploidias , Células Tumorales Cultivadas/patología , Células Tumorales Cultivadas/ultraestructuraAsunto(s)
Cesárea , Mola Hidatiforme/cirugía , Adulto , Femenino , Humanos , Mola Hidatiforme/diagnóstico , Mola Hidatiforme/patología , Recién Nacido , Embarazo , UltrasonografíaRESUMEN
A patient is reported for whom initial chromosome analysis indicated 45,X/46,XX/46,XX,10q- mosaicism. The clinical findings included hypothyroidism and a low red cell folate estimation. The deleted chromosome 10 was subsequently shown to be an extreme expression of the folate sensitive heritable fragile site at 10q23, and a possible association between this and the in vivo folate status of the patient is suggested.
Asunto(s)
Deleción Cromosómica , Fragilidad Cromosómica , Cromosomas Humanos Par 10 , Sitios Frágiles del Cromosoma , Ácido Fólico/metabolismo , Humanos , MosaicismoRESUMEN
The use of techniques for the production of prometaphase chromosomes leading to increased resolution of banding patterns has resulted in problems as well as advantages in their routine use. A simple technique utilising the folate antagonist methotrexate has been in use in this regional diagnostic cytogenetics centre for three years, and a number of chromosome abnormalities have been detected in cases previously reported as normal following G banding studies. With reference to this, the routine analysis of prometaphase-type chromosomes is discussed and assessed.
Asunto(s)
Bandeo Cromosómico/métodos , Metafase , Aberraciones Cromosómicas , Humanos , MetotrexatoRESUMEN
The clinical features of a family with inherited multiple meningiomas as the major manifestation of neurofibromatosis are presented. The value of noninvasive radiological screening investigations is emphasised. The results of cytogenetic and pathological studies on the family are presented and discussed with a review of the relevant literature.
Asunto(s)
Meningioma/genética , Neurofibromatosis 1/genética , Adulto , Aberraciones Cromosómicas , Trastornos de los Cromosomas , Femenino , Humanos , Masculino , Meningioma/análisis , Meningioma/patología , Neurofibromatosis 1/análisis , Neurofibromatosis 1/patología , Receptores de Estrógenos/análisis , Receptores de Progesterona/análisisRESUMEN
A recombinant rec (13), dup q chromosome was diagnosed in a 17-week fetus following amniocentesis. Subsequently, a familial pericentric inversion of chromosome 13 was seen to be segregating in the family and the same recombinant 13 was present in a mentally retarded aunt of the fetus. The clinical features of the carriers of the inversion product are discussed with reference to previous cases.